SyB L-1101
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SyB L-1101, covering 2016-09-14 to 2017-03-31. Get the full timeline:
Most recent: Clinical Trial Update: Long Term Safety Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study [Phase 1]